Platelet aggregation and thromboxane A2 formation in cat platelet rich plasma
- 1 January 1978
- journal article
- research article
- Published by Elsevier in Pharmacological Research Communications
- Vol. 10 (1) , 1-12
- https://doi.org/10.1016/s0031-6989(78)80057-5
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Synthesis of thromboxane A2 by non-aggregating dog platelets challenged with arachidonic acid or with prostaglandin H2Prostaglandins, 1977
- Selective inhibition of thromboxane A2 biosynthesis in blood plateletsNature, 1977
- : A selective inhibitor of thromboxane synthetaseProstaglandins, 1977
- A potent inhibitor of thromboxane A2 biosynthesis in aggregating human blood plateletsPharmacological Research Communications, 1977
- On the Formation and Effects of Thromboxane A2 in Human PlateletsActa Physiologica Scandinavica, 1976
- Intravenous arachidonate in the mouse: A model for the evaluation of antithrombotic drugsThrombosis Research, 1976
- Dog platelets fail to aggregate when they form aggregating substances upon stimulation with arachidonic acidEuropean Journal of Pharmacology, 1976
- Stroke in Rats Produced by Carotid Injection of Sodium ArachidonateScience, 1975
- Inhibition by sulfhydryl agents of arachidonic acid-induced platelet aggregation and release of potential inflammatory substancesProstaglandins, 1974
- Platelet Aggregation induced by Arachidonic Acid is accompanied by Release of Potential Inflammatory Mediators distinct from PGE2 and PGF2Nature New Biology, 1973